# Esketamine Combined With Dexmedetomidine Sedation in Head MRI Examination of Children With Autism Spectrum Disorder

> **NCT06633315** · PHASE2 · COMPLETED · sponsor: **Maternal and Child Health Hospital of Hubei Province** · enrollment: 300 (actual)

## Conditions studied

- Autism Spectrum Disorder
- Dexmedetomidine
- Esketamine
- Sedation

## Interventions

- **OTHER:** low dos dexmedetomidine
- **OTHER:** high dos dexmedetomidine
- **OTHER:** dexmedetomidine and esketamine

## Key facts

- **NCT ID:** NCT06633315
- **Lead sponsor:** Maternal and Child Health Hospital of Hubei Province
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-09-01
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2024-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06633315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06633315, "Esketamine Combined With Dexmedetomidine Sedation in Head MRI Examination of Children With Autism Spectrum Disorder". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06633315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*